Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Nurix revenue
Nurix's revenue is $54.5 million.
What is Nurix's revenue?
- Nurix's revenue growth from 2022 to 2024 is 41.22%.
- Nurix has 103 employees, and the revenue per employee ratio is $529,601.
- Nurix's peak quarterly revenue was $30.7M in 2023(q2).
- Nurix peak revenue was $77.0M in 2023.
- Nurix annual revenue for 2023 was 77.0M, 99.31% growth from 2022.
- Nurix annual revenue for 2024 was 54.5M, -29.15% growth from 2023.
On this page
Zippia finds jobs where you're a top candidate and applies on your behalf.
Nurix historical revenue
Nurix annual revenue
Nurix annual revenue over time
| Fiscal year / year | Nurix revenue |
|---|---|
| 2022 | $38.6M |
| 2023 | $77.0M |
| 2024 | $54.5M |
Nurix quarterly revenue over time
- Q1
- Q2
- Q3
- Q4
Nurix quarterly growth rate over time
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2022 | $9.6M | $11.4M | $10.8M | $6.8M |
| 2023 | $12.7M | $30.7M | $18.5M | $15.2M |
| 2024 | $16.6M | $12.1M | $12.6M | $13.3M |
| 2025 | $18.5M | - | - | - |
Nurix jobs nearby
Do you work at Nurix?
Is Nurix transparent about its revenue structure?
Nurix financial information
| Industry | Pharmaceuticals, Biotechnology & Life Sciences |
| Company Type | Public |
| Employees Number | 103 |
| Date Founded | 2012 |
| Headquarters | San Francisco, California |
| Number of Locations | 1 |
| Revenue | $54.5M |
| Net Income | -$180,360,000 |
| Tax Rate | -0.0% |
| Total Assets | $416,759,000 |
| Ticker | NRIX |
Nurix jobs you might like
Nurix financing
Nurix received early financing of $3.1M on 2012-05-17.
| Series | Round size | Date |
|---|---|---|
| Seed | $3.1M | 05/2012 |
| Series Unknown | $5.3M | 03/2013 |
| Series B | $25.1M | 05/2014 |
| Series C | $17M | 09/2015 |
| Private Equity | $120M | 03/2020 |
| Post Ipo Equity | $160.4M | 03/2021 |
Nurix investors
| Investors | Security type |
|---|---|
| Third Rock Ventures | Seed |
| The Column Group | Seed |
| Third Rock Ventures | Series Unknown |
| The Column Group | Series Unknown |
| Third Rock Ventures | Series B |
| The Column Group | Series B |
| EcoR1 Capital, LLC | Private Equity |
| Redmile Group | Private Equity |
| Bain Capital Life Sciences | Private Equity |
| Wellington Management | Private Equity |
| Third Rock Ventures | Private Equity |
| Foresite Capital | Private Equity |
| The Column Group | Private Equity |
| Boxer Capital | Private Equity |
Nurix competitors
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Cognition Therapeutics | - | $19.5M | 30 | - |
| Panacos Pharmaceuticals | - | - | 20 | - |
| Frequency Therapeutics | - | $2.3M | 83 | - |
| eFFECTOR Therapeutics | - | $42.0M | 24 | - |
| Kezar Life Sciences | - | $7.0M | 20 | - |
| Tetralogic Pharmaceuticals | - | - | 20 | - |
| Tensha Therapeutics | - | $180,000 | 5 | - |
| Ribometrix | - | $2.0M | 44 | - |
| Aquinox Pharmaceuticals | - | - | 9 | - |
Search for jobs
Related company revenues
Working at related companies
Related company jobs
Nurix highest paying jobs
Zippia gives an in-depth look into the details of Nurix, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Nurix. The employee data is based on information from people who have self-reported their past or current employments at Nurix. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Nurix. The data presented on this page does not represent the view of Nurix and its employees or that of Zippia.
Nurix may also be known as or be related to NURIX THERAPEUTICS, INC., Nurix, Nurix, Inc and Nurix, Inc.